Chronic Pain
The MD Magazine Chronic Pain condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Chronic Migraine: Study to Look at Long-Term Use of OnabotulinumtoxinA
A recently completed Phase III trial – called PREEMPT – established the efficacy and safety of onabotulinumtoxinA (marketed by Allergan under the brand name Botox®) in treating chronic migraine. Following those results, a new long-term trial is currently underway to analyze some of the clinical questions raised but not answered in PREEMPT.
Study results show that mood, whether positive or negative, may impact the discomfort associated with rheumatoid arthritis.
Does timing really make an impact when it comes to treating back pain? A new study weighed in on the importance early initiation of therapy in this patient population.
Merely being told that a treatment has analgesic effects may be all that a patient needs in order to experience pain relief, a new study suggested.
Opioids have been and continue to be a major source of relief for both chronic and acute pain sufferers. As the use of prescription opioid medications continues to rise, however, so does our knowledge about opioid dependence and opioid poisonings.
A recent study evaluated the potential methods of intra-articular corticosteroid injection in children with juvenile idiopathic arthritis, the most common chronic rheumatic disease in children.
Patient-controlled analgesia appears to be statistically and clinically superior to standard pain control in emergency department patients with non-traumatic abdominal pain.

Most Popular

$vacMongoViewPlus$ $vAR$